Harrow (HROW) Net Equity Issued and Repurchased (2012 - 2019)
Harrow (HROW) posted quarterly Net Equity Issued and Repurchased of -$89000.0 for Q4 2019, down 9000.0% quarter-over-quarter from $1000.0 in Q3 2018.
Harrow (HROW) Net Equity Issued and Repurchased (2012 - 2019) Analysis & Trends
Harrow's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at -$89000.0 for Q4 2019.
- In Q4 2019, Net Equity Issued and Repurchased changed N/A year-over-year to -$89000.0; the TTM figure through Dec 2019 stood at $431000.0 (down 32.87% YoY), while the FY2023 annual figure was $64.5 million, up 184.79% from the prior year.
- Net Equity Issued and Repurchased for Q4 2019 stood at -$89000.0, down from $1000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $11.1 million in Q1 2016, with the low at -$89000.0 in Q4 2019.
- The 4-year median for Net Equity Issued and Repurchased is $195000.0 (2016), against an average of $1.8 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -89,000.00 |
| Dec 31, 2019 | -89,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Sep 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 519,000.00 |
| Jun 30, 2018 | 519,000.00 |
| Mar 31, 2018 | 122,000.00 |
| Mar 31, 2018 | 122,000.00 |
| Dec 31, 2017 | 962,000.00 |
| Dec 31, 2017 | 962,000.00 |
| Sep 30, 2016 | 195,000.00 |
| Sep 30, 2016 | 195,000.00 |
| Mar 31, 2016 | 11.09 Mn |
| Mar 31, 2016 | 11.09 Mn |
| Mar 31, 2013 | 10.05 Mn |
| Mar 31, 2013 | 10.05 Mn |
| Dec 31, 2012 | -342,159.00 |
| Dec 31, 2012 | -342,159.00 |
| Sep 30, 2012 | 3.94 Mn |
| Sep 30, 2012 | 3.94 Mn |